Author:
AMEL Moein,BEBA POJARANİ Leyla,BURGAZ E. Vildan,TÜRKMEN Ömer
Publisher
EMU Journal of Pharmaceutical Sciences
Reference19 articles.
1. Benbir, G., & Guilleminault, C. (2006). Pramipexole: New use for an old drug - The potential use of pramipexole in the treatment of restless legs syndrome. Neuropsychiatric Disease and Treatment, 2(4), 393–405.
2. Deleu, D., Northway, M. G., & Hanssens, Y. (2002). Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson’s disease. Clinical Pharmacokinetics, 41(4), 261–309.
3. Dey, S., Pradhan, P. K., Upadhayay, U. M., Desai, K., & Niranjani, D. (2012). Method Development and Validation of Pramipexole by UV Spectrophotometric Method. Natural Science, 5(10), 5052–5054.
4. Dooley, M., & Markham, A. (1998). Pramipexole. A review of its use in the management of early and advanced Parkinson’s disease. Drugs and Aging, 12(6), 495–514.
5. Goldenberg, M. M. (2008). Medical management of Parkinson’s disease. P and T, 33(10).